OS was applied for the output of clinical prognosis, and we found that high levels of SMC1A, SMC1B, SMC2, and SMC4 expression were significantly associated with poorer OS in HCC patients (Figure 4A). This evidence concerns the gene SMC2 and hepatocellular carcinoma.